Evidence map›Paper›PMID 41224855›Full record

ArticleScientific reports2025

PKA prevents the resection of DNA double-strand breaks and favours nonhomologous end-joining.

Houaria Khater-Sellou, Elodie Dardillac, Elise Rabut, Indiana Magdalou, Vasily Ogryzko, Josée Guirouilh-Barbat, Bernard S Lopez

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Houaria Khater-SellouUniversité de Paris, INSERM U1016, UMR 8104 CNRS, Institut Cochin, Paris, France.
Elodie DardillacUniversité de Paris, INSERM U1016, UMR 8104 CNRS, Institut Cochin, Paris, France.
Elise RabutUniversité de Paris, INSERM U1016, UMR 8104 CNRS, Institut Cochin, Paris, France.
Indiana MagdalouCNRS UMR 8200, Institut de Cancérologie Gustave-Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
Vasily OgryzkoUMR 8126, Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France.
Josée Guirouilh-BarbatUniversité de Paris, INSERM U1016, UMR 8104 CNRS, Institut Cochin, Paris, France.
Bernard S LopezUniversité de Paris, INSERM U1016, UMR 8104 CNRS, Institut Cochin, Paris, France. bernard.lopez@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome rearrangement is a hallmark of cancer and ageing. DNA double-strand breaks (DSBs) are highly toxic lesions that can generate genome rearrangements. Several pathways compete for DSB repair, and selection of the appropriate repair process is critical for genetic stability. DSB repair acts according to two steps: (1) the choice between nonhomologous end-joining (NHEJ) and the resection of DNA ends, generating single-stranded DNA (ssDNA) and (2) on generated ssDNA, homologous recombination (HR) and sub-processes. Here, we show that 53BP1, which plays a prime role in the first step by protecting against resection and fostering NHEJ, physically interacts with the catalytic subunits of cAMP-dependent protein kinase A (PKAcs). PKA favours the recruitment of 53BP1 at DNA damage sites and consistently prevents resection, favouring NHEJ. Inhibition of PKA stimulated resection and concurrently reduced NHEJ. Conversely, the activation of PKA with 8-Bromo-cAMP stimulated NHEJ and reduced HR. These data provide new avenues for potential anticancer strategies. More generally, these findings underscore the high complexity of the regulation of DSB repair, identifying PKA as a novel participant in the DNA damage response that acts in the DSB repair process, which may be essential for maintaining genome integrity.

Indexed as

Cyclic AMP-Dependent Protein KinasesDNA Breaks, Double-StrandedDNA End-Joining RepairDNA, Single-StrandedHumansTumor Suppressor p53-Binding Protein 1Cyclic AMP-Dependent Protein KinasesDNA, Single-StrandedTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID41224855
PMCPMC12612049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.